Literature DB >> 690191

Absence of the platelet receptor for drug-dependent antibodies in the Bernard-Soulier syndrome.

T J Kunicki, M M Johnson, R H Aster.   

Abstract

The platelet membrane receptor for quinidine- and quinine-dependent antibodies was studied in three patients with the Bernard-Soulier syndrome (BSS) and in normal subjects with immunologic techniques based on the release of 51Cr from labeled platelets. The receptor could not be detected on BSS platelets but was present on platelets from each of 180 normal subjects. BSS platelets reacted normally with other allo- and autoantibodies. In confirmation of previous reports, BSS platelets were found to be deficient in glycoproteins Ib and Is. However, after apparently total cleavage of these proteins from the membrane of normal platelets by controlled hydrolysis with trypsin or chymotrypsin, 80% of the drug-dependent antibody receptor activity was retained. These observations suggest the existence of an additional, hitherto unrecognized membrane defect in Bernard-Soulier platelets.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 690191      PMCID: PMC371820          DOI: 10.1172/JCI109181

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  A MECHANISM OF CELL DESTRUCTION IN INDIVIDUALS SENSITIZED TO FOREIGN ANTIGENS AND ITS IMPLICATIONS IN AUTO-IMMUNITY. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

Authors:  N R SHULMAN
Journal:  Ann Intern Med       Date:  1964-03       Impact factor: 25.391

Review 2.  PLATELET AND LEUKOCYTE ISOANTIGENS AND THEIR ANTIBODIES: SEROLOGIC PHYSIOLOGIC AND CLINICAL STUDIES.

Authors:  N R SHULMAN; V J MARDER; M C HILLER; E M COLLIER
Journal:  Prog Hematol       Date:  1964

3.  Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis.

Authors:  J P Caen; S Levy-Toledano
Journal:  Nat New Biol       Date:  1973-08-01

4.  Platelet-function studies in the Bernard-Soulier syndrome.

Authors:  T C Bithell; S J Parekh; R R Strong
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

5.  Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis.

Authors:  D R Phillips; P P Agin
Journal:  J Biol Chem       Date:  1977-03-25       Impact factor: 5.157

6.  Human platelet glycoproteins. Further evidence that the "GP I band" from whole platelets contains three different polypeptides one of which may be involved in the interaction between platelets and Factor VIII.

Authors:  N O Solum; I Hagen; M Peterka
Journal:  Thromb Res       Date:  1977-01       Impact factor: 3.944

7.  Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface.

Authors:  T Okumura; G A Jamieson
Journal:  J Biol Chem       Date:  1976-10-10       Impact factor: 5.157

8.  Reduced thrombin binding and aggregation in Bernard-Soulier platelets.

Authors:  G A Jamieson; T Okumura
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia.

Authors:  T J Kunicki; R H Aster
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

10.  Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.

Authors:  M A Howard; R A Hutton; R M Hardisty
Journal:  Br Med J       Date:  1973-06-09
View more
  11 in total

1.  Drug-induced thrombocytopenia.

Authors:  P J Handagama; B F Feldman
Journal:  Vet Res Commun       Date:  1986-01       Impact factor: 2.459

2.  Platelet surface antigens: analysis by monoclonal antibodies. I. Antibodies. I. Immunological and biochemical studies.

Authors:  S Santoso; J Lohmeyer; H Rennich; K J Clemetson; C Mueller-Eckhardt
Journal:  Blut       Date:  1984-03

3.  Diagnosis of Bernard-Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood.

Authors:  R R Montgomery; T J Kunicki; C Taves; D Pidard; M Corcoran
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

4.  Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent.

Authors:  L De Marco; S S Shapiro
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

5.  Surface modifications in the platelets of a patient with alpha-N-acetyl-D-galactosamine residues, the Tn-syndrome.

Authors:  A T Nurden; D Dupuis; D Pidard; N Kieffer; T J Kunicki; J P Cartron
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

6.  Platelets have more than one binding site for von Willebrand factor.

Authors:  Z M Ruggeri; L De Marco; L Gatti; R Bader; R R Montgomery
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Human platelet glycoprotein IX: an adhesive prototype of leucine-rich glycoproteins with flank-center-flank structures.

Authors:  M J Hickey; S A Williams; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Quinine- and quinidine-dependent antiplatelet antibodies. Requirement of factor VIII-related antigen for platelet damage and for in vitro transformation of lymphocytes from patients with drug-induced thrombocytopenia.

Authors:  S L Pfueller; P K Hosseinzadeh; B G Firkin
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

9.  Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia.

Authors:  D J Christie; R H Aster
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia.

Authors:  P K Hosseinzadeh; B G Firkin; S L Pfueller
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.